Genmab A/S (GMAB)
57.06
+0.57
(+1.01%)
USD |
NASDAQ |
Oct 30, 16:00
57.15
+0.09
(+0.16%)
After-Hours: 20:00
Genmab 30-Day Average Daily Volume : 5.603M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 5.603M |
| October 29, 2026 | 5.405M |
| October 28, 2026 | 5.287M |
| October 27, 2026 | 4.407M |
| October 26, 2026 | 4.345M |
| October 23, 2026 | 4.143M |
| October 22, 2026 | 3.756M |
| October 21, 2026 | 3.634M |
| October 20, 2026 | 3.606M |
| October 19, 2026 | 3.531M |
| October 16, 2026 | 3.406M |
| October 15, 2026 | 3.346M |
| October 14, 2026 | 3.279M |
| October 13, 2026 | 3.241M |
| October 12, 2026 | 3.175M |
| October 09, 2026 | 3.121M |
| October 08, 2026 | 3.106M |
| October 07, 2026 | 3.065M |
| October 06, 2026 | 2.991M |
| October 05, 2026 | 2.879M |
| October 02, 2026 | 2.550M |
| October 01, 2026 | 2.581M |
| September 30, 2026 | 2.476M |
| September 29, 2026 | 2.394M |
| September 28, 2026 | 2.381M |
| Date | Value |
|---|---|
| September 25, 2026 | 2.402M |
| September 24, 2026 | 2.419M |
| September 23, 2026 | 2.453M |
| September 22, 2026 | 2.422M |
| September 21, 2026 | 2.438M |
| September 18, 2026 | 2.503M |
| September 17, 2026 | 2.587M |
| September 16, 2026 | 2.544M |
| September 15, 2026 | 2.491M |
| September 14, 2026 | 2.447M |
| September 11, 2026 | 2.471M |
| September 10, 2026 | 2.480M |
| September 09, 2026 | 2.485M |
| September 08, 2026 | 2.487M |
| September 04, 2026 | 2.487M |
| September 03, 2026 | 2.509M |
| September 02, 2026 | 2.517M |
| September 01, 2026 | 2.510M |
| August 31, 2026 | 2.487M |
| August 28, 2026 | 2.470M |
| August 27, 2026 | 2.507M |
| August 26, 2026 | 2.498M |
| August 25, 2026 | 2.453M |
| August 24, 2026 | 2.440M |
| August 21, 2026 | 2.483M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AbbVie, Inc. | 4.796M |
| Incyte Corp. | 1.814M |
| Ascendis Pharma A/S | 731224.8 |
| Zealand Pharma A/S | 388.53 |
| Novo Nordisk A/S | 13.38M |